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Abstract 32 
Oxysterols are oxygenated cholesterols that are important in many cell functions and they may also be 33 
indicative of certain diseases. The purpose of this work was to study the feasibility of ultra-34 
performance liquid chromatography–ion mobility–time-of-flight mass spectrometry (UPLC–IM–35 
TOFMS) using traveling wave cell in analyzing oxysterols and especially their isomers in biological 36 
samples. . Oxysterols were analyzed as their p-toluenesulfonyl isocyanate derivatives, which improved 37 
the separation of isomeric oxysterols by ion mobility and ionization efficiency in the electrospray 38 
ionization step. The UPLC–IM–TOFMS method was shown to be fast and to provide good quantitative 39 
performance.  The feasibility of the method was demonstrated in the analyses of oxysterols in fibroblast 40 
cell samples.  41 
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Introduction 57 
Oxysterols are oxygenated cholesterols that are either formed by cholesterol hydroxylases that belong to 58 
the cytochrome P450 family [1-3] or by auto-oxidation [4]. Oxysterols are involved in various biological 59 
events such as cholesterol homeostasis, apoptosis, cell differentiation, and signaling [5-8]. The most 60 
abundant oxysterols are 24(S)-, 27- and 7α-hydroxycholesterols in human serum [9]. The formation of 61 
24(S)-hydroxycholesterol is catalyzed by CYP46A1 in the brain whereas 27- and 7α-hydroxycholesterols 62 
are catalyzed by CYP27A1 and CYP7A1 in the liver [10, 11]. 24(S)- and 27-hydroxycholesterols have 63 
been linked with several neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease 64 
[12, 13]. Elevated levels of 24(S)-hydroxychloesterol have been detected in samples  of cerebrospinal 65 
fluid taken from patients that suffer from Alzheimer’s disease [12]. Though oxysterols have been linked 66 
with diseases, they are also part of normal cholesterol metabolism. Cholesterol in the brain is converted 67 
into 24(S)-hydroxycholesterol, which can permeate across the blood brain barrier into the circulation 68 
[14]. Recently, it has been shown that oxysterols have a role in dopaminergic neurogenesis [15]. The 69 
addition of exogenous 22-hydroxycholesterol caused a 2-fold increase in dopaminergic neurogenesis in 70 
mouse embryo cells compared to controls [15]. Oxysterols, such as 22(R)-hydroxycholesterol, 20(S)-71 
hydroxycholesterol, and 22(S)-hydroxycholesterol induced alkaline phosphatase activity, which is an 72 
early marker of osteogenic differentiation [16, 17]. 73 
Highly sensitive and selective analytical methods are needed for the analysis oxysterols in complex 74 
biological samples. The gold standard for the analysis of oxysterols is gas chromatography–mass 75 
spectrometry (GC–MS) [18-21], which is performed after derivatization of the oxysterols. One such 76 
derivatization is by trimethylsilylation, which makes them more volatile and thermally stable for the 77 
analysis. Liquid chromatography–mass spectrometry (LC-MS) [22], with electrospray ionization (ESI) 78 
[23, 24] or atmospheric pressure chemical ionization (APCI) [25] or atmospheric pressure 79 
photoionization (APPI) [26] has been increasingly used for the analysis of oxysterols. Although APCI 80 
[25] and APPI [26] provide high ionization efficiency for non-derivatized oxysterols, ESI is the preferred 81 
method due to its superior sensitivity for derivatized oxysterols [27]. Several derivatization procedures 82 
have been used for the LC–ESI–MS analysis of oxysterols such as derivatization to picolinyl esters, 83 
nicotinyl esters, N,N-dimethylglycine esters, oximes, and Girard hydrazones [22]. In addition to its high 84 
sensitivity, the high separation power of the chromatographic method is needed in order to separate 85 
different isomeric oxysterols, which is not possible by mass spectrometry alone because the 86 
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fragmentation behaviour of isomeric oxysterols are very similar. The separation of oxysterols is possible 87 
with GC [21] and LC [23]. However, the separation of isomeric oxysterols require relatively long run 88 
times, which significantly increase the total analyses times.  Therefore, faster analytical methods are 89 
needed for the determination and analysis of oxysterols in order to increase sample throughput.  90 
Ion mobility–mass spectrometry (IM–MS) is a powerful tool in bioanalysis and it has been increasingly 91 
used along with the development of commercial instruments. For example, IM-MS is used in 92 
metabolomics, in proteomics and in targeted analysis [28-30]. IM–MS provides high sensitivity, high 93 
specificity and analysis times that can be measured on millisecond timescales. Analytes are separated by 94 
IM–MS in the gas phase when traveling through a drift gas (normally N2) with a velocity that is dependent 95 
on the charge, shape, size, polarity, and collision cross section (CCS) of the analyte [29, 31]. The CCS 96 
provides an additional identification parameter in IM–MS in addition to the drift time, the m/z value and 97 
fragmentation pattern and it can be estimated by calibrating the IMS using compounds with known CCSs. 98 
The IM combined with LC–MS is also increasingly used in bioanalytics [32-34], because IM provides 99 
an additional degree of separation and thus significantly improved peak capacity and specificity. This 100 
can be particularly beneficial for example in the analysis of complex biological samples and in the 101 
separation of isomeric compounds [35, 36]. 102 
The recently introduced traveling wave ion mobility (TWIM) provides a new mode of ion separation 103 
prior MS analysis. In TWIM ions are accumulated in the trap cell and released into the mobility cell by 104 
continuous voltage pulses providing high ion transmission and good separation efficiency [37]. The 105 
TWIM–MS provides high sensitivity, specificity, and analysis times on a millisecond timescale and the 106 
method has been increasingly used in bioanalytical applications [38-40].  107 
In this study we have investigated for the first time the feasibility of UPLC–TWIM–TOFMS in the  108 
analysis of oxysterols.  The oxysterols were derivatized by p-toluenesulfonyl isocyanate (PTSI) in order 109 
to increase the respective CCS, which thus increases the separation power of IM and enhances ionization 110 
efficiency of oxysterols in electrospray ionization (ESI). PTSI derivatization was selected as the method, 111 
which has been applied successfully earlier for the separation of steroid isomers by TWIM [33]. The aim 112 
of the study was to improve sample throughput by using UPLC–TWIM–TOFMS that provides improved 113 
separation efficiency and thus faster analysis of oxysterol isomers than commonly used LC-MS or GC-114 
MS methods. Furthermore, we have investigated the feasibility of the UPLC–TWIM–TOFMS method 115 
in quantitative analysis of oxysterols in fibroblast cell samples.    116 
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Materials and methods 117 
Chemicals 118 
Ultra LC–MS grade methanol (MeOH) and acetonitrile (ACN) were purchased from Actu-All Chemicals 119 
(Oss, The Netherlands). Water was purified using a Millipore Milli-Q Gradient A10 purification system 120 
(Molsheim, France). 22-hydroxycholesterol (22-OH-chl, cholest-5-ene-3β,22-diol, 7α-121 
hydroxycholesterol (7α-OH-chl, 5-cholesten-3β,7α-diol) and 7β-hydroxycholesterol (7β-OH-chl, 5-122 
cholesten-3β,7β-diol) were purchased from Fountain Limited (Naxxar, Malta), 24(S)-hydroxycholesterol 123 
(24(S)-OH-chl, cholest-5-ene-3β,24α-diol) from AH diagnostics Oy (Helsinki, Finland), 27-124 
hydroxycholesterol (27-OH-chl, cholest-5-ene-3β,26-diol) from Santa Cruz Biotechnology, Inc. 125 
(Heidelberg, Germany) and 7-ketocholesterol (7-ketochl, 3β-hydroxy-5-cholesten-7-one) and 27-126 
hydroxycholesterol-d6 (d6-27-OH-Chl, 25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol) from 127 
Avanti Polar Lipids (Alabaster, AL, USA). The p-toluenesulfonyl isocyanate (PTSI, 96%), poly-DL-128 
alanine and analytical grade ammonium acetate (99%) were purchased from Sigma-Aldrich (St. Louis, 129 
MO, USA). 130 
Sample preparation and derivatization 131 
A stock solution (1 mg mL-1) of each standard compound used was prepared by dissolving it in methanol. 132 
Further dilutions of working solutions were also prepared in methanol. A sample or working standard 133 
solution in a vial was evaporated to dryness under nitrogen flow. The derivatization reaction was 134 
performed according to the method described by Zuo et al. [41]. A 100 µL volume of ACN was added 135 
to the vial followed by 20 µL of PTSI solution (100 µL mL-1 in ACN). The solution in the vial was 136 
agitated by a vortex mixer for 2 min and the reaction was stopped by adding 20 µL of H2O. The PTSI 137 
derivatization reaction is shown in Fig. S1 and the PTSI derivatized oxysterols used in this study are 138 
shown in Fig. S2.  139 
Newborn human foreskin fibroblasts (ATCC, CRL-2429) were cultured in Dulbecco’s modified Eagle’s 140 
medium (DMEM) with glutamine, 10% fetal bovine serum (Gibco, Carlsbad, CA, USA), and 1% mixture 141 
of penicillin, streptomycin, fungizone (Gibco), and incubated in a CO2 incubator (5% CO2) at 37°C. 142 
Fibroblasts were cultured in T-165 flasks. The medium was removed and the cells were washed twice 143 
with phosphate buffered saline. Subsequently, MeOH:H2O (50:50) was added to the cells, collected in a 144 
tube, sonicated for 10 minutes and centrifuged at 10 000g for 10 minutes. The supernatant was removed 145 
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and the pellet was then extracted in triplicate by adding 0.5 mL cyclohexane:ethyl acetate (3:1) containing 146 
7 ng mL-1 of d6-27-OH-Chl as an internal standard to the Eppendorf tubes, then vortex mixing and 147 
sonicating each replicate in an ultrasonic bath for 15 min. The Eppendorf tubes were centrifuged at 4°C 148 
and 13 200 rpm (19500 rfc) for 10 min. The supernatant was transferred to a new Eppendorf tube. The 149 
remaining cell pellet was re-extracted with 0.5 mL of cyclohexane:ethyl acetate (3:1) in the ultrasonic 150 
bath and centrifuged as described above. After centrifugation the supernatants were combined and 151 
extracted with 200 µL of H2O. The organic layer was saved and evaporated to dryness in a SpeedVac 152 
evaporator. The derivatization was performed as described above. 153 
UPLC–IM–TOFMS 154 
A Waters Synapt G2-S Q-TOF HDMS (Waters, Wilmslow, UK) mass spectrometer equipped with a 155 
traveling wave ion mobility cell was used in the IM–MS analysis. The mass spectrometer was operated 156 
in negative ion ESI mode using the resolution of 20000 FWHM. Capillary voltage was 2.5 kV, source 157 
temperature 120 °C, desolvation temperature 450 °C, desolvation gas flow 800 L h-1 and nebulizer gas 158 
pressure 6.0 bar. Sampling cone voltage was set to 40 V and source offset to 80 V. The acquisition mass 159 
range was m/z 50-1200.  160 
The optimization of the method and the acquisition of the mass spectra of the analytes were acquired by 161 
direct infusion of standard sample solution (derivatized oxysterols in ACN) at the flow rate of 10 µL 162 
min-1. The infusion flow was combined with the flow (400 µL min-1) of 10 mM ammonium acetate in 163 
MeOH from a Waters UPLC binary solvent manager before the ion source.  164 
A Waters Acquity UPLC (Waters) was used in the analysis of oxysterols by UPLC–IM–TOFMS. The 165 
column was Waters Acquity BEH C18, (2.1 x 100 mm, 1.7 µm) and the column temperature was 45 °C. 166 
Milli-Q water (A) and 10 mM ammonium acetate in methanol (B) were used as the mobile phases for 167 
the gradient elution. The gradient was 0-1 min 50% B  100% B, 1-3 min 100% B, and equilibration 168 
with 50% of B for 2 min. The flow rate was 0.4 mL min-1 and the injection volume was 5 µL. The samples 169 
were injected using a Waters UPLC sample manager.  170 
The optimal settings for the TWIM cell were the following: helium cell gas flow rate: 180 mL min-1, IM 171 
cell gas flow rate: 90 mL min-1 (3.0 mbar), IM wave height: 40.0 V, and IM wave velocity linear ramp 172 
300-1000 m s-1. The IM buffer gas was nitrogen. 173 
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The effect of the N2 buffer gas pressure (2.5-3.5 mbar) was studied. The peak-to-peak (Rp-p) resolutions 174 
of the adjacent peaks were calculated according to equations presented in Supplementary material. The 175 
CCS of the analytes were determined using 10 µg mL-1 poly-DL-alanine as a calibrant. The calibration 176 
curves were plotted according to TWIM CCS values of poly-DL-alanine molecules in the literature [42]. 177 
The CCS values and the concentrations in the quantitative analytes were determined from driftograms 178 
using Driftscope software.    179 
Results and discussion 180 
The oxysterol isomers were not separated in their native forms by IM because they had very similar CCSs 181 
and also due to having similar strengths of their ion-molecule interactions with the drift gas. The 182 
ionization efficiency of oxysterols with ESI was relatively poor as they lack an ionic group and their 183 
proton affinities were relatively low due to their nonpolar character. The PTSI derivatization of the 184 
oxysterols improved the separation efficiency due to their increased ion-molecule interactions and CCSs. 185 
The derivatization also improved the ionization efficiency and all the derivatives produced very intense 186 
deprotonated molecule with minimal fragmentation and provided good sensitivity in the IM–MS 187 
analysis.   188 
 189 
The effect of drift gas (N2) pressure (2.5, 3.0, and 3.5 bar) on ion mobility separation efficiency was 190 
studied by using selected positional isomers of PTSI-derviatized oxysterols, namely: the PTSI-191 
derivatives of 22-OH-, 24(S)-OH- and 27-OH-cholesterols (Fig. S3). At every chosen pressure setting 192 
22-OH-cholesterol was fully separated from 24(S)-OH- and 27-OH-cholesterols, but 24(S)-OH- and 27-193 
OH-cholesterols were only partly separated from each other (Figure 3). At pressures of 2.5, 3.0, and 3.5 194 
bar the respective Rp-p between 22-OH- and 24(S)-OH-cholesterols were 0.54, 0.93, and 1.25, whereas 195 
between 24(S)-OH- and 27-OH-cholesterols the  corresponding Rp-p were 0.54, 0,54 and 0.46. The results 196 
show that the resolution between 22-OH- and 24(S)-OH-cholesterols increased when the pressure of N2 197 
was raised, although the resolution between 24(S)-OH- and 27-OH-cholesterols did not change 198 
significantly. On the other hand, the sensitivity was decreased by about 4-fold when the pressure was 199 
increased from 2.5 bar to 3.5 bar but decreased only by about 1.5-fold when the pressure was increased 200 
from 2.5 bar to 3.0 bar. The decreased sensitivity at higher drift gas pressures is due to the decreased ion 201 
transmission through the TWIM cell. The drift gas pressure of 3.0 bar provided the best compromise 202 
between resolution and sensitivity based on these results.  203 
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 204 
The drift times and collision cross sections of the PTSI derivatives of the six studied oxysterols are 205 
presented in Table 1. The CCS was 274.26 Å2 for 7-ketocholesterol and between 284.14 and 309.34 Å2 206 
for the other oxysterols. The CCS of 7-ketocholesterol was smaller because it produced a mono-PTSI 207 
derivate whereas the other oxysterols have two hydroxyl groups to produce di-PTSI-derivatives. Thus, 208 
7-ketocholesterol was well separated from the other oxysterols. A more branched structure causes a larger 209 
collision cross section in 7-OH-, 7-OH- and 22-OH-cholesterols than in 24(S)-OH- and 27-OH-210 
cholesterols where the site of the derivatization is at the end of the side-chain (Fig. S2). The PTSI-211 
derivatized oxysterols 22-OH-, 24(S)-OH-, 27-OH-cholesterols were at least partly separated from each 212 
other (Fig. 1A). Both 7-OH- and 7-OH-cholesterol standards, when analyzed separately, showed two 213 
peaks in their selected mobility traces (Fig. S4 B and C) that is obviously due to formation of two 214 
protomers. The same was not observed with other oxysterols. It seems that the derivatized oxysterols 215 
having both PTSI groups at the ring structure (carbon 3 and 7) favors separation of protomers compared 216 
to the oxysterols having other PTSI group at carbon 3 and other at the side chain. When 7-OH- and 7-217 
OH-cholesterol standards were analyzed as a mixture, the protomer 1 of 7-OH-cholesterol was 218 
separated but the protomer 2 of 7-OH-cholesterol and the protomers 1 and 2 of 7-OH-cholesterol 219 
overlapped and were not separated from each other (Fig. 1 and Fig. S 4A). Furthermore, the protomers 220 
of 7-OH- and 7-OH-cholesterol anomers overlapped with the 24(S)-OH- and 22-OH-cholesterols (Fig. 221 
1). These results show that the separation power of IM alone is insufficient for full separation of all the 222 
oxysterols and more specific methods are needed.  223 
 224 
UPLC–IM–TOFMS of fibroblast cell samples 225 
The UPLC was interfaced with the IM–TOFMS in order to improve the specificity in the analysis of the 226 
oxysterols. The  2-D separation map of  [M-H]- ions (m/z 796.3791 +/- 10 ppm) (Fig. 2) shows that the 227 
PTSI derivatives of 22-OH-, 24(S)-OH-, 27-OH-cholesterols were separated from 7-OH-, 7-OH-228 
cholesterols by UPLC–IM–TOFMS that was not possible by IM–TOFMS alone. Similar to that found 229 
for the IM–TOFMS analysis, the the protomer 1 of 7-OH-cholesterol was separated, but the protomer 230 
2  of 7-OH-cholesteroloverlapped with 7-OH-cholesterol protomers (Fig. 2). Therefore, the peak areas 231 
of 7-OH- and 7-OH cholesterols were summarized in quantitative analysis. However, it is possible to 232 
estimate the concentrations of 7-OH- and 7-OH-cholesterol separately based on the separated peak of 233 
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the protomer 1 of 7-OH-cholesterol. The peak area of the protomer 1 of 7-OH cholesterol is 25% of 234 
the peak area of the protomer 2 of 7-OH cholesterol (Fig. 4S) that provides estimation of the total 235 
concentration of 7-OH-cholesterol in quantitative analysis. When the estimated peak area of protomer 236 
2 of 7-OH-cholesterol is subtracted from the overlapping peak of the protomer 2 of 7-OH-cholesterol 237 
and the protomers 1 and 2 of 7-OH-cholesterol the total concentration of 7-OH-cholesterol can be 238 
estimated. However, the repeatability of the formation of the protomers must be studied in more detail 239 
before this estimation can be utilized in quantitative analysis of 7-OH- and 7-OH-cholesterols. The 240 
analysis of 7-ketocholesterol was not a problem, since it separated well from other oxysterols by UPLC–241 
IM and it appeared at a different m/z ratio than other oxysterols. The improved specificity owing to IM 242 
allowed to use fast gradients in UPLC separation that significantly shortened the separation times (about 243 
2 min) compared to the LC-MS methods (7-15 min) presented in the literature [20-25]. 244 
The quantitative performance of analysis of UHPLC–IMS–MS in the analysis of oxysterols was studied 245 
with respect to the limits of detection (LOD), the limits of quantification (LOQ), linearity, and intra- and 246 
inter-day repeatability. The LODs (at S/N ≥3) were 0.5-1.0 ng mL-1 and LOQs 1.0-5.0 ng mL-1, which 247 
indicates good sensitivity for the method. Linearity of the calibration curves and intra- and inter-day 248 
repeatabilities were determined using analyte to d6-27-OH-Chl internal standard (ISTD) peak area ratios. 249 
Calibration curves were determined using the linear regression with 1/X weighting within a concentration 250 
range of 0.5 – 250 ng mL-1. The coefficients of determination (R2) for the calibration curves were better 251 
than 0.995 for all the compounds and thus acceptable. Five replicate injections of 10 ng mL-1 of standard 252 
sample were made for intra- and inter-day repeatability tests. The relative standard deviations (%RSD) 253 
for intra-day and inter-day repeatabilities for the analyte/ISTD peak area ratios were below 8% and 19%, 254 
respectively, which indicate acceptable levels of repeatability. These results show good quantitative 255 
performance of the method for the analysis oxysterols.  256 
The feasibility of the UPLC–IM–TOFMS method for the analysis of biological samples was studied by 257 
quantifying oxysterols in fibroblast cell samples that contained four million cells (Fig. 2B). The use of 258 
high resolution mass spectrometry with a mass window of 10 ppm ensured the specific analysis of the 259 
selected oxysterols without significant background disturbances from the sample matrix. All six 260 
compounds, 22-OH-, 24(S)-OH-, 27-OH-, 7-OH-cholesterols and 7-ketocholesterol, were detected in the 261 
fibroblast cell samples (Table 3, Fig 2B). The concentrations of 7α-OH- + 7β-OH-cholesterols and 7-262 
ketocholesterol were 47.8 ng mL-1 and 5.9 ng mL-1 (1.67 and 0.21 ng/million cells, respectively). These 263 
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compounds were clearly detected with good repeatability in three replicate analysis. The 22-OH-, 24(S)-264 
OH-, 27-OH-cholesterols were also detected but their concentrations were below the LOQ but above 265 
LOD. It can be estimated, however, that the concentrations of 22-OH-oxysterols in the cell samples were 266 
between 0,5 – 1 ng mL-1 (0.018 – 0.035 ng/million cells) and the concentrations of 24(S)-OH- and 27-267 
OH-oxysterols between 1-5 ng mL-1 (0.035 – 0.18 ng/million cells).   268 
Conclusions 269 
The separation of isomeric oxysterols is of high importance as it facilitates getting more detailed and 270 
therefore useful information on the role of oxysterols in biological systems. We showed that UPLC–IM–271 
TOFMS provides a potentially useful and reliable method for the analysis of oxysterols in biological 272 
samples. The PTSI-derivatization of oxysterols improves separation of isomeric oxysterols in addition to 273 
improving their ionization efficiencies in electrospray ionization. However, the full separation of 274 
isomeric oxysterols was not possible solely by IM and the combination of UPLC–IM was needed in order 275 
to enhance separation efficiency. However, the partial separation of isomeric oxysterols by IM made 276 
possible to use rapid gradients in UPLC  in order to achieve fast analysis with acceptable separation. The 277 
method was shown to provide acceptable quantitative performance and its feasibility was successfully 278 
demonstrated in the analyses of six oxysterols in fibroblast cell samples.  279 
Acknowledgements 280 
We gratefully acknowledge the Finnish Funding Agency for Innovation (Tekes) large strategic research 281 
opening project no. 40395/13 for financial support. 282 
References 283 
[1] V. Mutemberezi, O. Guillemot-Legris, G.G. Muccioli, Oxysterols: From cholesterol metabolites to key 284 
mediators, Progress in Lipid Research, 64 (2016) 152-169. 285 
[2] I.A. Pikuleva, Cholesterol-metabolizing cytochromes P450, Drug Metab Dispos, 34 (2006) 513-520. 286 
[3] I. Björkhem, Five decades with oxysterols, Biochimie, 95 (2013) 448-454. 287 
[4] G.J. Schroepfer, Oxysterols: Modulators of cholesterol metabolism and other processes, Physiological 288 
Reviews, 80 (2000) 361-554. 289 
[5] R. Kuver, Mechanisms of oxysterol-induced disease: insights from the biliary system, Clinical Lipidology, 7 290 
(2012) 537-548. 291 
[6] V.M. Olkkonen, O. Béaslas, E. Nissilä, Oxysterols and Their Cellular Effectors, Biomolecules, 2 (2012). 292 
[7] J. Makoukji, G.G. Shackleford, D. Meffre, J. Grenier, P. Liere, J.-M.A. Lobaccaro, M. Schumacher, C. Massaad, 293 
Interplay between LXR and Wnt/beta-Catenin Signaling in the Negative Regulation of Peripheral Myelin Genes 294 
by Oxysterols, Journal of Neuroscience, 31 (2011) 9620-9629. 295 
[8] N.J. Spann, C.K. Glass, Sterols and oxysterols in immune cell function, Nat Immunol, 14 (2013) 893-900. 296 
11 
 
[9] V.V.R. Bandaru, N.J. Haughey, Quantitative detection of free 24S-hydroxycholesterol, and 27-297 
hydroxycholesterol from human serum, BMC Neuroscience, 15 (2014) 1-9. 298 
[10] I. Bjorkhem, Rediscovery of cerebrosterol, Lipids, 42 (2007) 5-14. 299 
[11] P.V. Luoma, Cytochrome P450 - Physiological key factor against cholesterol accumulation and the 300 
atherosclerotic vascular process, Annals of Medicine, 39 (2007) 359-370. 301 
[12] P. Schonknecht, D. Lutjohann, J. Pantel, H. Bardenheuer, T. Hartmann, K. von Bergmann, K. Beyreuther, J. 302 
Schroder, Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared 303 
to healthy controls, Neuroscience Letters, 324 (2002) 83-85. 304 
[13] I. Bjorkhem, M. Heverin, V. Leoni, S. Meaney, U. Diczfalusy, Oxysterols and Alzheimer's disease, Acta 305 
neurologica Scandinavica. Supplementum, 185 (2006) 43-49. 306 
[14] D. Lütjohann, K. Von Bergmann, 24S-Hydroxycholesterol: A Marker of Brain Cholesterol Metabolism, 307 
Pharmacopsychiatry, 36 (2003) S102-S106. 308 
[15] P. Sacchetti, K.M. Sousa, A.C. Hall, I. Liste, K.R. Steffensen, S. Theofilopoulos, C.L. Parish, C. Hazenberg, L. 309 
Auml;hrlund-Richter, O. Hovatta, J.A. Gustafsson, E. Arenas, Liver X Receptors and Oxysterols Promote Ventral 310 
Midbrain Neurogenesis In Vivo and in Human Embryonic Stem Cells, Cell Stem Cell, 5 (2009) 409-419. 311 
[16] H.T. Kha, B. Basseri, D. Shouhed, J. Richardson, S. Tetradis, T.J. Hahn, F. Parhami, Oxysterols regulate 312 
differentiation of mesenchymal stem cells: Pro-bone and anti-fat, Journal of Bone and Mineral Research, 19 313 
(2004) 830-840. 314 
[17] T.L. Aghaloo, C.M. Amantea, C.M. Cowan, J.A. Richardson, B.M. Wu, F. Parhami, S. Tetradis, Oxysterols 315 
enhance osteoblast differentiation in vitro and bone healing in vivo, Journal of Orthopaedic Research, 25 (2007) 316 
1488-1497. 317 
[18] W.J. Griffiths, Y. Wang, Analysis of oxysterol metabolomes, Biochimica et Biophysica Acta (BBA) - Molecular 318 
and Cell Biology of Lipids, 1811 (2011) 784-799. 319 
[19] H.-F. Schoett, D. Luetjohann, Validation of an isotope dilution gas chromatography-mass spectrometry 320 
method for combined analysis of oxysterols and oxyphytosterols in serum samples, Steroids, 99 (2015) 139-150. 321 
[20] W.J. Griffiths, P.J. Crick, Y. Wang, Methods for oxysterol analysis: Past, present and future, Biochem 322 
Pharmacol, 86 (2013) 3-14. 323 
[21] S. Dzeletovic, O. Breuer, E. Lund, U. Diczfalusy, Determination of Cholesterol Oxidation Products in Human 324 
Plasma by Isotope Dilution-Mass Spectrometry, Anal Biochem, 225 (1995) 73-80. 325 
[22] W.J. Griffiths, J. Abdel-Khalik, P.J. Crick, E. Yutuc, Y. Wang, New methods for analysis of oxysterols and related 326 
compounds by LC-MS, J. Steroid Biochem. Mol. Biol., (2015) Ahead of Print. 327 
[23] J.G. McDonald, D.D. Smith, A.R. Stiles, D.W. Russell, A comprehensive method for extraction and quantitative 328 
analysis of sterols and secosteroids from human plasma, J Lipid Res, 53 (2012) 1399-1409. 329 
[24] Z. Pataj, G. Liebisch, G. Schmitz, S. Matysik, Quantification of oxysterols in human plasma and red blood cells 330 
by liquid chromatography high-resolution tandem mass spectrometry, J. Chromatogr. A, 1439 (2016) 82-88. 331 
[25] V. Mutemberezi, J. Masquelier, O. Guillemot-Legris, G.G. Muccioli, Development and validation of an HPLC-332 
MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations 333 
in metabolic syndrome, Anal Bioanal Chem, 408 (2016) 733-745. 334 
[26] L. Ahonen, F.B.R. Maire, M. Savolainen, J. Kopra, R.J. Vreeken, T. Hankemeier, T. Myohanen, P. Kylli, R. 335 
Kostiainen, Analysis of oxysterols and vitamin D metabolites in mouse brain and cell line samples by ultra-high-336 
performance liquid chromatography-atmospheric pressure photoionization-mass spectrometry, J. Chromatogr. 337 
A, 1364 (2014) 214-222. 338 
[27] A. Honda, K. Yamashita, T. Hara, T. Ikegami, T. Miyazaki, M. Shirai, G. Xu, M. Numazawa, Y. Matsuzaki, Highly 339 
sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS, J Lipid Res, 50 (2009) 340 
350-357. 341 
[28] G. Paglia, M. Kliman, E. Claude, S. Geromanos, G. Astarita, Applications of ion-mobility mass spectrometry 342 
for lipid analysis, Anal Bioanal Chem, 407 (2015) 4995-5007. 343 
12 
 
[29] C. Lapthorn, F. Pullen, B.Z. Chowdhry, Ion mobility spectrometry-mass spectrometry (IMS-MS) of small 344 
molecules: Separating and assigning structures to ions, Mass Spectrom. Rev., 32 (2013) 43-71. 345 
[30] Y. Zhong, S.-J. Hyung, B.T. Ruotolo, Ion mobility-mass spectrometry for structural proteomics, Expert Rev. 346 
Proteomics, 9 (2012) 47-58. 347 
[31] F. Lanucara, S.W. Holman, C.J. Gray, C.E. Eyers, The power of ion mobility-mass spectrometry for structural 348 
characterization and the study of conformational dynamics, Nat. Chem., 6 (2014) 281-294. 349 
[32] C.W.N. Damen, G. Isaac, J. Langridge, T. Hankemeier, R.J. Vreeken, Enhanced lipid isomer separation in 350 
human plasma using reversed-phase UPLC with ion-mobility/high-resolution MS detection, J Lipid Res, 55 (2014) 351 
1772-1783. 352 
[33] T. Pacini, W. Fu, S. Gudmundsson, A.E. Chiaravalle, S. Brynjolfson, B.O. Palsson, G. Astarita, G. Paglia, 353 
Multidimensional Analytical Approach Based on UHPLC-UV-Ion Mobility-MS for the Screening of Natural 354 
Pigments, Analytical Chemistry, 87 (2015) 2593-2599. 355 
[34] A. Thomas, W. Schaenzer, M. Thevis, Determination of human insulin and its analogues in human blood 356 
using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS), Drug Test. Anal., 6 (2014) 357 
1125-1132. 358 
[35] L. Ahonen, M. Fasciotti, G.B. af Gennas, T. Kotiaho, R.J. Daroda, M. Eberlin, R. Kostiainen, Separation of 359 
steroid isomers by ion mobility mass spectrometry, Journal of Chromatography A, 1310 (2013) 133-137. 360 
[36] E. Reading, J. Munoz-Muriedas, A.D. Roberts, G.J. Dear, C.V. Robinson, C. Beaumont, Elucidation of Drug 361 
Metabolite Structural Isomers Using Molecular Modeling Coupled with Ion Mobility Mass Spectrometry, Anal. 362 
Chem. (Washington, DC, U. S.), 88 (2016) 2273-2280. 363 
[37] A.A. Shvartsburg, R.D. Smith, Fundamentals of Traveling Wave Ion Mobility Spectrometry, Analytical 364 
chemistry, 80 (2008) 9689-9699. 365 
[38] A.B. Kanu, P. Dwivedi, M. Tam, L. Matz, H.H. Hill, Ion mobility-mass spectrometry, Journal of Mass 366 
Spectrometry, 43 (2008) 1-22. 367 
[39] P.M. Lalli, B.A. Iglesias, H.E. Toma, G.F. de Sa, R.J. Daroda, J.C. Silva, J.E. Szulejko, K. Araki, M.N. Eberlin, 368 
Protomers: formation, separation and characterization via travelling wave ion mobility mass spectrometry, 369 
Journal of Mass Spectrometry, 47 (2012) 712-719. 370 
[40] G.A. Bataglion, G.H. Martins Ferreira Souza, G. Heerdt, N.H. Morgon, J.D. Lisboa Dutra, R.O. Freire, M.N. 371 
Eberlin, A. Tata, Separation of glycosidic catiomers by TWIM-MS using CO2 as a drift gas, Journal of Mass 372 
Spectrometry, 50 (2015) 336-343. 373 
[41] M. Zuo, M.-j. Gao, Z. Liu, L. Cai, G.-L. Duan, p-Toluenesulfonyl isocyanate as a novel derivatization reagent 374 
to enhance the electrospray ionization and its application in the determination of two stereo isomers of 3-375 
hydroxyl-7-methyl-norethynodrel in plasma, Journal of Chromatography B, 814 (2005) 331-337. 376 
[42] J.G. Forsythe, A.S. Petrov, C.A. Walker, S.J. Allen, J.S. Pellissier, M.F. Bush, N.V. Hud, F.M. Fernandez, Collision 377 
cross section calibrants for negative ion mode traveling wave ion mobility-mass spectrometry, Analyst, 140 378 
(2015) 6853-6861. 379 
 380 
 381 
 382 
 383 
 384 
13 
 
Figures 385 
Figure 1. Selected ion mobility responses of the [M-H]- ions (m/z 795.3718 +/- 10 ppm) of the PTSI-386 
derivatized A) 22-, 24(S)- and 27-OH-cholesterol and B) 7α-OH- and 7β-OH-cholesterol.   387 
 388 
Figure 2. 2-D separation map of the [M-H]- ions (m/z 796.3791 +/- 10 ppm) of  22-OH-, 24(S)-OH-, 27-389 
OH-, and 7α-OH-/7β-OH-cholesterols of A) standard sample (2 ng mL-1) and B) fibroblast sample (4 390 
million cells) by UPLC–IM–TOFMS. P1 = protomer 1 and P2 = protomer 2.   391 
 392 
